| Year |
Citation |
Score |
| 2022 |
Denys A, Norman A, Perrien DS, Suva LJ, Simon L, McDaniel LS, Ferguson T, Pedersen K, Welsh D, Molina PE, Ronis MJ. Impact of Alcohol on Bone Health in People Living With HIV: Integrating Clinical Data From Serum Bone Markers With Morphometric Analysis in a Non-Human Primate Model. Jbmr Plus. 7: e10703. PMID 36699637 DOI: 10.1002/jbm4.10703 |
0.307 |
|
| 2022 |
Mohamed FF, Chavez MB, Huggins S, Bertels J, Falck A, Suva LJ, Foster BL, Gaddy D. Dentoalveolar Defects of Hypophosphatasia are Recapitulated in a Sheep Knock-In Model. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 36053890 DOI: 10.1002/jbmr.4666 |
0.334 |
|
| 2022 |
Wagner BM, Robinson JW, Prickett TCR, Espiner EA, Khosla S, Gaddy D, Suva LJ, Potter LR. Guanylyl Cyclase-B Dependent Bone Formation in Mice is Associated with Youth, Increased Osteoblasts, and Decreased Osteoclasts. Calcified Tissue International. PMID 35947145 DOI: 10.1007/s00223-022-01014-7 |
0.392 |
|
| 2022 |
Buettmann EG, Goldscheitter GM, Hoppock GA, Friedman MA, Suva LJ, Donahue HJ. Similarities Between Disuse and Age-Induced Bone Loss. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 35773785 DOI: 10.1002/jbmr.4643 |
0.396 |
|
| 2022 |
Sherman KM, Williams DK, Welsh CA, Cooper AM, Falck A, Huggins S, Bokhari RS, Gaddy D, McKelvey KD, Dawson LA, Suva LJ. Low bone mass and impaired fracture healing in mouse models of Trisomy21 (Down syndrome). Bone. 162: 116471. PMID 35716916 DOI: 10.1016/j.bone.2022.116471 |
0.304 |
|
| 2021 |
Dolan CP, Imholt F, Yang TJ, Bokhari R, Gregory J, Yan M, Qureshi O, Zimmel K, Sherman K, Falck A, Yu L, Leininger E, Brunauer R, Suva LJ, Gaddy D, et al. Mouse Digit Tip Regeneration is Mechanical Load-dependent. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 34783092 DOI: 10.1002/jbmr.4470 |
0.318 |
|
| 2021 |
Mohan M, Kumar M, Samant R, Van Hemert R, Tian E, Desai S, van Rhee F, Thanendrarajan S, Schinke C, Suva LJ, Sharma S, Milad M, Kendrick S, Zangari M. Bone remineralization Of Lytic Lesions in Multiple Myeloma --The Arkansas Experience. Bone. 115876. PMID 33556629 DOI: 10.1016/j.bone.2021.115876 |
0.398 |
|
| 2020 |
Suva LJ, Cooper A, Watts AE, Ebetino FH, Price J, Gaddy D. Bisphosphonates in veterinary medicine: The new horizon for use. Bone. 142: 115711. PMID 33141069 DOI: 10.1016/j.bone.2020.115711 |
0.489 |
|
| 2020 |
Robinson JW, Blixt NC, Norton A, Mansky KC, Ye Z, Aparicio C, Wagner BM, Benton AM, Warren GL, Khosla S, Gaddy D, Suva LJ, Potter LR. Male mice with elevated C-type natriuretic peptide-dependent guanylyl cyclase-B activity have increased osteoblasts, bone mass and bone strength. Bone. 115320. PMID 32179168 DOI: 10.1016/J.Bone.2020.115320 |
0.417 |
|
| 2020 |
Williams AE, Watt J, Robertson LW, Gadupudi G, Osborn ML, Soares MJ, Iqbal K, Pedersen KB, Shankar K, Littleton S, Maimone C, Eti NA, Suva LJ, Ronis MJJ. Skeletal Toxicity of Coplanar Polychlorinated Biphenyl Congener 126 in the Rat is Aryl Hydrocarbon Receptor-Dependent. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 32119087 DOI: 10.1093/Toxsci/Kfaa030 |
0.445 |
|
| 2019 |
Suva LJ, Westhusin ME, Gaddy D, Long CR. Engineering bone phenotypes in domestic animals: Unique resources for enhancing musculoskeletal research. Bone. 115119. PMID 31712131 DOI: 10.1016/J.Bone.2019.115119 |
0.385 |
|
| 2019 |
Huseman CJ, Sigler DH, Welsh TH, Suva LJ, Vogelsang MM, Dominguez BJ, Huggins S, Paulk C. Skeletal response to whole body vibration and dietary calcium and phosphorus in growing pigs. Journal of Animal Science. PMID 31265734 DOI: 10.1093/Jas/Skz189 |
0.32 |
|
| 2019 |
Mitchell A, Watts AE, Ebetino FH, Suva LJ. Bisphosphonate use in the horse: what is good and what is not? Bmc Veterinary Research. 15: 211. PMID 31234844 DOI: 10.1186/S12917-019-1966-X |
0.443 |
|
| 2019 |
Suva LJ. A Link between the Gut and Bone: Bone Health Impacted by Changes in Gut Microbiota. The American Journal of Pathology. 189: 229-230. PMID 30665557 DOI: 10.1016/j.ajpath.2018.11.004 |
0.367 |
|
| 2019 |
Little SE, Allaway HC, Bokhari RS, Seidel DV, Wahl KL, Turner ND, Ford JR, Suva L, Bloomfield SA. Can Acute Galactic Cosmic Radiation-induced Bone Loss Be Mitigated By Dietary Modulation Of Inflammatory Cytokines?: 1486 Board #248 May 30 9:30 AM - 11:00 AM Medicine and Science in Sports and Exercise. 51: 406. DOI: 10.1249/01.Mss.0000561717.28075.Cd |
0.411 |
|
| 2018 |
Williams DK, Pinzón C, Huggins S, Pryor JH, Falck A, Herman F, Oldeschulte J, Chavez MB, Foster BL, White SH, Westhusin ME, Suva LJ, Long CR, Gaddy D. Genetic engineering a large animal model of human hypophosphatasia in sheep. Scientific Reports. 8: 16945. PMID 30446691 DOI: 10.1038/S41598-018-35079-Y |
0.36 |
|
| 2018 |
Williams DK, Parham SG, Schryver E, Akel NS, Shelton RS, Webber J, Swain FL, Schmidt J, Suva LJ, Gaddy D. Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice. Jbmr Plus. 2: 47-54. PMID 30283889 DOI: 10.1002/jbm4.10025 |
0.485 |
|
| 2018 |
Watt J, Alund AW, Pulliam CF, Mercer KE, Suva LJ, Chen JR, Ronis MJJ. NOX4 deletion in male mice exacerbates the effect of ethanol on trabecular bone and osteoblastogenesis. The Journal of Pharmacology and Experimental Therapeutics. PMID 29653963 DOI: 10.1124/Jpet.117.247262 |
0.444 |
|
| 2018 |
Zangari M, Yoo H, Shin IJ, Yoon D, Suva LJ. Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma. Journal of Bone Oncology. 12: 19-22. PMID 29556454 DOI: 10.1016/J.Jbo.2018.02.005 |
0.417 |
|
| 2018 |
Tamplen M, Fowler T, Markey J, Knott PD, Suva LJ, Alliston T. Treatment with anti-Sclerostin antibody to stimulate mandibular bone formation. Head & Neck. PMID 29522281 DOI: 10.1002/Hed.25128 |
0.366 |
|
| 2017 |
Johnson RW, Suva LJ. Hallmarks of Bone Metastasis. Calcified Tissue International. PMID 29138883 DOI: 10.1007/s00223-017-0362-4 |
0.563 |
|
| 2017 |
Kamalakar A, Washam CL, Akel NS, Allen BJ, Williams DK, Swain FL, Leitzel K, Lipton A, Gaddy D, Suva LJ. PTHrP(12-48) Modulates the Bone Marrow Microenvironment and Suppresses Human Osteoclast Differentiation and Lifespan. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 28370412 DOI: 10.1002/Jbmr.3142 |
0.589 |
|
| 2016 |
Alund AW, Mercer KE, Suva LJ, Pulliam CF, Chen JR, Badger TM, Van Remmen H, Ronis MJ. Reactive Oxygen Species Differentially Regulate Bone Turnover in an Age-Specific Manner in Catalase Transgenic Female Mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27189961 DOI: 10.1124/Jpet.116.233213 |
0.429 |
|
| 2016 |
Suva LJ, Gaddy D. Back to the Future: Evaluation of the Role of Glutamate in Bone Cells. Calcified Tissue International. PMID 27061091 DOI: 10.1007/S00223-016-0135-5 |
0.408 |
|
| 2016 |
Zangari M, Suva LJ. The effects of proteasome inhibitors on bone remodeling in multiple myeloma. Bone. 86: 131-138. PMID 26947893 DOI: 10.1016/j.bone.2016.02.019 |
0.403 |
|
| 2016 |
Stine KC, Wahl EC, Liu L, Skinner RA, VanderSchilden J, Bunn RC, Montgomery CO, Suva LJ, Aronson J, Becton DL, Nicholas RW, Swearingen CJ, Lumpkin CK. Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. PMID 26867804 DOI: 10.1002/Jor.23192 |
0.418 |
|
| 2016 |
Li J, Pan Q, Rowan PD, Trotter TN, Peker D, Regal KM, Javed A, Suva LJ, Yang Y. Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells. Oncotarget. PMID 26849235 DOI: 10.18632/oncotarget.7170 |
0.464 |
|
| 2015 |
Makhoul I, Montgomery CO, Gaddy D, Suva LJ. The best of both worlds-managing the cancer, saving the bone. Nature Reviews. Endocrinology. PMID 26503674 DOI: 10.1038/Nrendo.2015.185 |
0.534 |
|
| 2015 |
Trotter TN, Li M, Pan Q, Peker D, Rowan PD, Li J, Zhan F, Suva LJ, Javed A, Yang Y. Myeloma cell-derived Runx2 promotes myeloma progression in bone. Blood. 125: 3598-608. PMID 25862559 DOI: 10.1182/blood-2014-12-613968 |
0.485 |
|
| 2015 |
Fowler TW, Kamalakar A, Akel NS, Kurten RC, Suva LJ, Gaddy D. Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures. Journal of Cell Science. 128: 683-94. PMID 25609708 DOI: 10.1242/Jcs.157834 |
0.465 |
|
| 2015 |
Suva LJ, Makhoul I. Bone: Will breast cancer chemoprevention stand on 'solid bone'? Nature Reviews. Endocrinology. 11: 138-9. PMID 25511313 DOI: 10.1038/nrendo.2014.220 |
0.554 |
|
| 2015 |
Zangari M, Yoo H, Suva L, Yoon D. Thymus-Derived PTH (TPTH) Is Increased after Thyroparathyroidectomy in C57BL6/Kalwrij Mice and Modulates Mouse Sensitivity to 5TGM1 Myeloma Cell Line Blood. 126: 5335-5335. DOI: 10.1182/Blood.V126.23.5335.5335 |
0.344 |
|
| 2014 |
Yang CS, Mercer KE, Alund AW, Suva LJ, Badger TM, Ronis MJ. Genistein supplementation increases bone turnover but does not prevent alcohol-induced bone loss in male mice. Experimental Biology and Medicine (Maywood, N.J.). 239: 1380-9. PMID 24872432 DOI: 10.1177/1535370214532759 |
0.419 |
|
| 2014 |
Kamalakar A, Bendre MS, Washam CL, Fowler TW, Carver A, Dilley JD, Bracey JW, Akel NS, Margulies AG, Skinner RA, Swain FL, Hogue WR, Montgomery CO, Lahiji P, Maher JJ, ... ... Suva LJ, et al. Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans. Bone. 61: 176-85. PMID 24486955 DOI: 10.1016/J.Bone.2014.01.015 |
0.803 |
|
| 2014 |
Stine KC, Wahl EC, Liu L, Skinner RA, Vanderschilden J, Bunn RC, Montgomery CO, Suva LJ, Aronson J, Becton DL, Nicholas RW, Swearingen CJ, Lumpkin CK. Cisplatin inhibits bone healing during distraction osteogenesis. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 32: 464-70. PMID 24259375 DOI: 10.1002/Jor.22527 |
0.439 |
|
| 2014 |
Gruenwald K, Castagnola P, Besio R, Dimori M, Chen Y, Akel NS, Swain FL, Skinner RA, Eyre DR, Gaddy D, Suva LJ, Morello R. Sc65 is a novel endoplasmic reticulum protein that regulates bone mass homeostasis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 29: 666-75. PMID 23959653 DOI: 10.1002/Jbmr.2075 |
0.401 |
|
| 2013 |
Ruan J, Trotter TN, Nan L, Luo R, Javed A, Sanderson RD, Suva LJ, Yang Y. Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease. Bone. 57: 10-7. PMID 23895995 DOI: 10.1016/J.Bone.2013.07.024 |
0.504 |
|
| 2013 |
Washam CL, Byrum SD, Leitzel K, Ali SM, Tackett AJ, Gaddy D, Sundermann SE, Lipton A, Suva LJ. Identification of PTHrP(12-48) as a plasma biomarker associated with breast cancer bone metastasis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 972-83. PMID 23462923 DOI: 10.1158/1055-9965.Epi-12-1318-T |
0.482 |
|
| 2013 |
Spatz JM, Ellman R, Cloutier AM, Louis L, van Vliet M, Suva LJ, Dwyer D, Stolina M, Ke HZ, Bouxsein ML. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 865-74. PMID 23109229 DOI: 10.1002/jbmr.1807 |
0.41 |
|
| 2013 |
McKelvey KD, Fowler TW, Akel NS, Kelsay JA, Gaddy D, Wenger GR, Suva LJ. Low bone turnover and low bone density in a cohort of adults with Down syndrome. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 24: 1333-8. PMID 22903293 DOI: 10.1007/S00198-012-2109-4 |
0.442 |
|
| 2012 |
Fowler TW, McKelvey KD, Akel NS, Vander Schilden J, Bacon AW, Bracey JW, Sowder T, Skinner RA, Swain FL, Hogue WR, Leblanc DB, Gaddy D, Wenger GR, Suva LJ. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment. Plos One. 7: e42967. PMID 22916188 DOI: 10.1371/Journal.Pone.0042967 |
0.462 |
|
| 2012 |
Mercer KE, Wynne RA, Lazarenko OP, Lumpkin CK, Hogue WR, Suva LJ, Chen JR, Mason AZ, Badger TM, Ronis MJ. Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice. The Journal of Pharmacology and Experimental Therapeutics. 343: 401-12. PMID 22892342 DOI: 10.1124/Jpet.112.197038 |
0.317 |
|
| 2012 |
Liu L, Aronson J, Huang S, Lu Y, Czernik P, Rahman S, Kolli V, Suva LJ, Lecka-Czernik B. Rosiglitazone inhibits bone regeneration and causes significant accumulation of fat at sites of new bone formation. Calcified Tissue International. 91: 139-48. PMID 22752619 DOI: 10.1007/S00223-012-9623-4 |
0.486 |
|
| 2012 |
Byrum SD, Washam CL, Montgomery CO, Tackett AJ, Suva LJ. Proteomic technologies for the study of osteosarcoma. Sarcoma. 2012: 169416. PMID 22550414 DOI: 10.1155/2012/169416 |
0.379 |
|
| 2012 |
Suva LJ, Griffin RJ. The irradiation of bone: old idea, new insight. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 747-8. PMID 22434644 DOI: 10.1002/Jbmr.1586 |
0.406 |
|
| 2012 |
Garg TK, Szmania SM, Khan JA, Hoering A, Malbrough PA, Moreno-Bost A, Greenway AD, Lingo JD, Li X, Yaccoby S, Suva LJ, Storrie B, Tricot G, Campana D, Shaughnessy JD, et al. Highly activated and expanded natural killer cells for multiple myeloma immunotherapy. Haematologica. 97: 1348-56. PMID 22419581 DOI: 10.3324/Haematol.2011.056747 |
0.416 |
|
| 2012 |
Suva LJ. Imaging the vasculature by microCT; ain't no bones about it. Bone. 50: 400. PMID 21964410 DOI: 10.1016/j.bone.2011.08.034 |
0.314 |
|
| 2012 |
Perrien DS, Nicks KM, Liu L, Akel NS, Bacon AW, Skinner RA, Swain FL, Aronson J, Suva LJ, Gaddy D. Inhibin A enhances bone formation during distraction osteogenesis. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 30: 288-95. PMID 21809377 DOI: 10.1002/Jor.21501 |
0.439 |
|
| 2011 |
Jia D, Gaddy D, Suva LJ, Corry PM. Rapid loss of bone mass and strength in mice after abdominal irradiation. Radiation Research. 176: 624-35. PMID 21859327 DOI: 10.1667/Rr2505.1 |
0.357 |
|
| 2011 |
Clines GA, Mohammad KS, Grunda JM, Clines KL, Niewolna M, McKenna CR, McKibbin CR, Yanagisawa M, Suva LJ, Chirgwin JM, Guise TA. Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 2523-36. PMID 21698666 DOI: 10.1002/jbmr.450 |
0.408 |
|
| 2011 |
Cooney CA, Jousheghany F, Yao-Borengasser A, Phanavanh B, Gomes T, Kieber-Emmons AM, Siegel ER, Suva LJ, Ferrone S, Kieber-Emmons T, Monzavi-Karbassi B. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Research : Bcr. 13: R58. PMID 21658254 DOI: 10.1186/Bcr2895 |
0.363 |
|
| 2011 |
Suva LJ, Brander BE, Makhoul I. Update on bone-modifying agents in metastatic breast cancer. Nature Reviews. Endocrinology. 7: 380-1. PMID 21610686 DOI: 10.1038/nrendo.2011.80 |
0.506 |
|
| 2011 |
Ponnapakkam T, Katikaneni R, Miller E, Ponnapakkam A, Hirofumi S, Miyata S, Suva LJ, Sakon J, Matsushita O, Gensure RC. Monthly administration of a novel PTH-collagen binding domain fusion protein is anabolic in mice Calcified Tissue International. 88: 511-520. PMID 21512758 DOI: 10.1007/s00223-011-9485-1 |
0.419 |
|
| 2011 |
Gaddy D, Fowler TW, Suva LJ. Hormonal causes of menopausal bone resorption. Current Osteoporosis Reports. 9: 43-5. PMID 21487955 DOI: 10.1007/S11914-011-0055-2 |
0.433 |
|
| 2011 |
Suva LJ, Washam C, Nicholas RW, Griffin RJ. Bone metastasis: mechanisms and therapeutic opportunities. Nature Reviews. Endocrinology. 7: 208-18. PMID 21200394 DOI: 10.1038/Nrendo.2010.227 |
0.548 |
|
| 2011 |
Zangari M, Yaccoby S, Pappas L, Cavallo F, Kumar NS, Ranganathan S, Suva LJ, Gruenwald JM, Kern S, Zhan F, Esseltine D, Tricot G. A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients. Haematologica. 96: 333-6. PMID 20952514 DOI: 10.3324/haematol.2010.031302 |
0.391 |
|
| 2011 |
Washam C, Byrum S, Leitzel K, Suhail A, Lipton A, Suva L. P4-16-01: Proteomic Analysis of Patient Plasma Identifies Parathyroid Hormone Related Protein (PTHrP12-48) as a Potential Biomarker of Breast Cancer Bone Metastasis. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-16-01 |
0.521 |
|
| 2010 |
Yang Y, Ren Y, Ramani VC, Nan L, Suva LJ, Sanderson RD. Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL. Cancer Research. 70: 8329-38. PMID 20978204 DOI: 10.1158/0008-5472.Can-10-2179 |
0.498 |
|
| 2010 |
Jia D, Koonce NA, Halakatti R, Li X, Yaccoby S, Swain FL, Suva LJ, Hennings L, Berridge MS, Apana SM, Mayo K, Corry PM, Griffin RJ. Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent. Radiation Research. 173: 809-17. PMID 20518660 DOI: 10.1667/Rr1734.1 |
0.36 |
|
| 2010 |
Coleman RE, Lipton A, Roodman GD, Guise TA, Boyce BF, Brufsky AM, Clézardin P, Croucher PI, Gralow JR, Hadji P, Holen I, Mundy GR, Smith MR, Suva LJ. Metastasis and bone loss: advancing treatment and prevention. Cancer Treatment Reviews. 36: 615-20. PMID 20478658 DOI: 10.1016/J.Ctrv.2010.04.003 |
0.48 |
|
| 2010 |
Suva LJ. Adjuvant bisphosphonates in breast cancer: the ABCSG-12 study. Current Osteoporosis Reports. 8: 57-9. PMID 20425611 DOI: 10.1007/s11914-010-0012-5 |
0.322 |
|
| 2010 |
Byrum S, Montgomery CO, Nicholas RW, Suva LJ. The promise of bone cancer proteomics. Annals of the New York Academy of Sciences. 1192: 222-9. PMID 20392240 DOI: 10.1111/j.1749-6632.2009.05220.x |
0.488 |
|
| 2010 |
Nicks KM, Fowler TW, Akel NS, Perrien DS, Suva LJ, Gaddy D. Bone turnover across the menopause transition : The role of gonadal inhibins. Annals of the New York Academy of Sciences. 1192: 153-60. PMID 20392231 DOI: 10.1111/J.1749-6632.2009.05349.X |
0.466 |
|
| 2010 |
Kelly T, Suva LJ, Nicks KM, MacLeod V, Sanderson RD. Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 25: 1295-304. PMID 20200931 DOI: 10.1002/Jbmr.16 |
0.6 |
|
| 2010 |
Byrum S, Siegel ER, Bhattacharyya S, Suva LJ. Proteomics of bone cancer Bone Cancer. 171-180. DOI: 10.1016/B978-0-12-374895-9.00014-1 |
0.452 |
|
| 2009 |
Suva LJ. Sclerostin and the unloading of bone. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 24: 1649-50. PMID 19757998 DOI: 10.1359/jbmr.090815 |
0.46 |
|
| 2009 |
Nicks KM, Perrien DS, Akel NS, Suva LJ, Gaddy D. Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin. Molecular and Cellular Endocrinology. 310: 11-20. PMID 19615428 DOI: 10.1016/J.Mce.2009.07.001 |
0.439 |
|
| 2009 |
Suva LJ, Griffin RJ, Makhoul I. Mechanisms of bone metastases of breast cancer. Endocrine-Related Cancer. 16: 703-13. PMID 19443538 DOI: 10.1677/Erc-09-0012 |
0.528 |
|
| 2009 |
Pennisi A, Li X, Ling W, Khan S, Gaddy D, Suva LJ, Barlogie B, Shaughnessy JD, Aziz N, Yaccoby S. Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease. British Journal of Haematology. 145: 775-87. PMID 19388929 DOI: 10.1111/J.1365-2141.2009.07696.X |
0.417 |
|
| 2009 |
Mohammad KS, Chen CG, Balooch G, Stebbins E, McKenna CR, Davis H, Niewolna M, Peng XH, Nguyen DH, Ionova-Martin SS, Bracey JW, Hogue WR, Wong DH, Ritchie RO, Suva LJ, et al. Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. Plos One. 4: e5275. PMID 19357790 DOI: 10.1371/Journal.Pone.0005275 |
0.44 |
|
| 2008 |
Coleman RE, Guise TA, Lipton A, Roodman GD, Berenson JR, Body JJ, Boyce BF, Calvi LM, Hadji P, McCloskey EV, Saad F, Smith MR, Suva LJ, Taichman RS, Vessella RL, et al. Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 6387-95. PMID 18927277 DOI: 10.1158/1078-0432.Ccr-08-1572 |
0.479 |
|
| 2008 |
Sebastian EM, Suva LJ, Friedman PA. Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure. Bone. 43: 1022-30. PMID 18761112 DOI: 10.1016/J.Bone.2008.07.250 |
0.342 |
|
| 2008 |
Bhattacharyya S, Siegel ER, Achenbach SJ, Khosla S, Suva LJ. Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 23: 1106-17. PMID 18302502 DOI: 10.1359/jbmr.080235 |
0.338 |
|
| 2008 |
Suva LJ, Hartman E, Dilley JD, Russell S, Akel NS, Skinner RA, Hogue WR, Budde U, Varughese KI, Kanaji T, Ware J. Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease. The American Journal of Pathology. 172: 430-9. PMID 18187573 DOI: 10.2353/ajpath.2008.070417 |
0.42 |
|
| 2008 |
Kapoor P, Suva LJ, Welch DR, Donahue HJ. Osteoprotegrin and the bone homing and colonization potential of breast cancer cells. Journal of Cellular Biochemistry. 103: 30-41. PMID 17471510 DOI: 10.1002/Jcb.21382 |
0.642 |
|
| 2008 |
Jia D, Halakatti R, Jackson C, Suva L, Li X, Yaccoby S, Hennings L, Griffin R, Corry P. Inhibition of multiple myeloma (MM) growth and preservation of bone with combined radiotherapy and anti-angiogenic agent Bone. 43: S79-S80. DOI: 10.1016/J.Bone.2008.07.089 |
0.426 |
|
| 2007 |
Bhattacharyya S, Byrum S, Siegel ER, Suva LJ. Proteomic analysis of bone cancer: a review of current and future developments. Expert Review of Proteomics. 4: 371-8. PMID 17552921 DOI: 10.1586/14789450.4.3.371 |
0.412 |
|
| 2007 |
Maeda Y, Nakamura E, Nguyen MT, Suva LJ, Swain FL, Razzaque MS, Mackem S, Lanske B. Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proceedings of the National Academy of Sciences of the United States of America. 104: 6382-7. PMID 17409191 DOI: 10.1073/pnas.0608449104 |
0.4 |
|
| 2007 |
Lazarenko OP, Rzonca SO, Hogue WR, Swain FL, Suva LJ, Lecka-Czernik B. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology. 148: 2669-80. PMID 17332064 DOI: 10.1210/en.2006-1587 |
0.486 |
|
| 2007 |
Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, Swain FL, Skinner RA, Hogue WR, Nicks KM, Pierson TM, Suva LJ, Gaddy D. Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology. 148: 1654-65. PMID 17194739 DOI: 10.1210/En.2006-0848 |
0.771 |
|
| 2007 |
Clines GA, Mohammad KS, Bao Y, Stephens OW, Suva LJ, Shaughnessy JD, Fox JW, Chirgwin JM, Guise TA. Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation. Molecular Endocrinology (Baltimore, Md.). 21: 486-98. PMID 17068196 DOI: 10.1210/me.2006-0346 |
0.444 |
|
| 2007 |
Zangari M, Cavallo F, Suva L, Dilley J, Trico G, Barlogie B, Burns MJ, Passera R, Boccadoro M, Esseltine D, Yaccoby S. Prospective Evaluation of the Bone Anabolic Effect of Bortezomib in Relapsed Multiple Myeloma (MM) Patients. Blood. 110: 2719-2719. DOI: 10.1182/Blood.V110.11.2719.2719 |
0.466 |
|
| 2006 |
Marguiles AG, Klimberg VS, Bhattacharrya S, Gaddy D, Suva LJ. Genomics and proteomics of bone cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6217s-6221s. PMID 17062704 DOI: 10.1158/1078-0432.Ccr-06-1070 |
0.435 |
|
| 2006 |
Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, Vessella R, Corey E, Padalecki S, Suva L, Chirgwin JM. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6213s-6216s. PMID 17062703 DOI: 10.1158/1078-0432.Ccr-06-1007 |
0.571 |
|
| 2006 |
Lipton A, Berenson JR, Body JJ, Boyce BF, Bruland OS, Carducci MA, Cleeland CS, Clohisy DR, Coleman RE, Cook RJ, Guise TA, Pearse RN, Powles TJ, Rogers MJ, Roodman GD, ... ... Suva LJ, et al. Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6209s-6212s. PMID 17062702 DOI: 10.1158/1078-0432.Ccr-06-1213 |
0.486 |
|
| 2006 |
Carcel-Trullols J, Stanley JS, Saha R, Shaaf S, Bendre MS, Monzavi-Karbassi B, Suva LJ, Kieber-Emmons T. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant. International Journal of Oncology. 28: 1173-83. PMID 16596233 DOI: 10.3892/Ijo.28.5.1173 |
0.795 |
|
| 2006 |
Perrien DS, Achenbach SJ, Bledsoe SE, Walser B, Suva LJ, Khosla S, Gaddy D. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. The Journal of Clinical Endocrinology and Metabolism. 91: 1848-54. PMID 16449331 DOI: 10.1210/Jc.2005-2423 |
0.397 |
|
| 2006 |
Lazarenko OP, Rzonca SO, Suva LJ, Lecka-Czernik B. Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. Bone. 38: 74-84. PMID 16137931 DOI: 10.1016/j.bone.2005.07.008 |
0.348 |
|
| 2005 |
Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, Martinez A, Guise TA, Chirgwin JM, Gaddy D, Suva LJ. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Research. 65: 11001-9. PMID 16322249 DOI: 10.1158/0008-5472.Can-05-2630 |
0.795 |
|
| 2005 |
Wahl EC, Perrien DS, Aronson J, Liu Z, Fletcher TW, Skinner RA, Feige U, Suva LJ, Badger TM, Lumpkin CK. Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis. Alcoholism, Clinical and Experimental Research. 29: 1466-72. PMID 16131855 DOI: 10.1097/01.Alc.0000174695.09579.11 |
0.381 |
|
| 2005 |
Suva LJ, Gaddy D, Perrien DS, Thomas RL, Findlay DM. Regulation of bone mass by mechanical loading: microarchitecture and genetics. Current Osteoporosis Reports. 3: 46-51. PMID 16036101 DOI: 10.1007/S11914-005-0003-0 |
0.427 |
|
| 2005 |
Kelly T, Suva LJ, Huang Y, Macleod V, Miao HQ, Walker RC, Sanderson RD. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. Cancer Research. 65: 5778-84. PMID 15994953 DOI: 10.1158/0008-5472.Can-05-0749 |
0.513 |
|
| 2005 |
Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proceedings of the National Academy of Sciences of the United States of America. 102: 3324-9. PMID 15728361 DOI: 10.1073/Pnas.0408742102 |
0.449 |
|
| 2005 |
Yang Y, Macleod V, Bendre M, Huang Y, Theus AM, Miao HQ, Kussie P, Yaccoby S, Epstein J, Suva LJ, Kelly T, Sanderson RD. Heparanase promotes the spontaneous metastasis of myeloma cells to bone. Blood. 105: 1303-9. PMID 15471949 DOI: 10.1182/Blood-2004-06-2141 |
0.771 |
|
| 2004 |
Sanderson RD, Yang Y, Suva LJ, Kelly T. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis. Matrix Biology : Journal of the International Society For Matrix Biology. 23: 341-52. PMID 15533755 DOI: 10.1016/J.Matbio.2004.08.004 |
0.315 |
|
| 2004 |
Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LJ. Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. Journal of Theoretical Biology. 229: 293-309. PMID 15234198 DOI: 10.1016/J.Jtbi.2004.03.023 |
0.445 |
|
| 2004 |
Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B. Bone Is a Target for the Antidiabetic Compound Rosiglitazone Endocrinology. 145: 401-406. PMID 14500573 DOI: 10.1210/En.2003-0746 |
0.484 |
|
| 2003 |
Bendre M, Gaddy D, Nicholas RW, Suva LJ. Breast cancer metastasis to bone: it is not all about PTHrP. Clinical Orthopaedics and Related Research. S39-45. PMID 14600591 DOI: 10.1097/01.Blo.0000093844.72468.F4 |
0.807 |
|
| 2003 |
Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone. 33: 28-37. PMID 12919697 DOI: 10.1016/S8756-3282(03)00086-3 |
0.802 |
|
| 2003 |
Skerry TM, Suva LJ. Investigation of the regulation of bone mass by mechanical loading: from quantitative cytochemistry to gene array. Cell Biochemistry and Function. 21: 223-9. PMID 12910474 DOI: 10.1002/cbf.1077 |
0.325 |
|
| 2002 |
Perrien DS, Brown EC, Fletcher TW, Irby DJ, Aronson J, Gao GG, Skinner RA, Hogue WR, Feige U, Suva LJ, Ronis MJ, Badger TM, Lumpkin CK. Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis. The Journal of Pharmacology and Experimental Therapeutics. 303: 904-8. PMID 12438508 DOI: 10.1124/Jpet.102.039636 |
0.435 |
|
| 2002 |
Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, Suva LJ. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Research. 62: 5571-9. PMID 12359770 |
0.803 |
|
| 2002 |
Aronson J, Liu L, Liu Z, Gao GG, Perrien DS, Brown EC, Skinner RA, Thomas JR, Morris KD, Suva LJ, Badger TM, Lumpkin CK. Decreased endosteal intramembranous bone formation accompanies aging in a mouse model of distraction osteogenesis E-Biomed. 3: 7-16. DOI: 10.1089/152489002760269667 |
0.419 |
|
| 2001 |
Nuttall ME, Pendrak I, Emery JG, Nadeau DP, Fisher PW, Nicholson TA, Zhu Y, Suva LJ, Kingsbury WD, Gowen M. Antagonism of oestrogen action in human breast and endometrial cells in vitro: Potential novel antitumour agents Cancer Chemotherapy and Pharmacology. 47: 437-443. PMID 11391860 DOI: 10.1007/s002800000259 |
0.312 |
|
| 2000 |
Colleran PN, Wilkerson MK, Bloomfield SA, Suva LJ, Turner RT, Delp MD. Alterations in skeletal perfusion with simulated microgravity: a possible mechanism for bone remodeling. Journal of Applied Physiology (Bethesda, Md. : 1985). 89: 1046-54. PMID 10956349 DOI: 10.1152/Jappl.2000.89.3.1046 |
0.377 |
|
| 2000 |
Ferrari SL, Traianedes K, Thorne M, Lafage-Proust MH, Genever P, Cecchini MG, Behar V, Bisello A, Chorev M, Rosenblatt M, Suva LJ. A role for N-cadherin in the development of the differentiated osteoblastic phenotype. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 15: 198-208. PMID 10703921 DOI: 10.1359/jbmr.2000.15.2.198 |
0.326 |
|
| 2000 |
Prichett WP, Patton AJ, Field JA, Brun KA, Emery JG, Tan KB, Rieman DJ, McClung HA, Nadeau DP, Mooney JL, Suva LJ, Gowen M, Nuttall ME. Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone Journal of Cellular Biochemistry. 76: 639-650. PMID 10653983 DOI: 10.1002/(SICI)1097-4644(20000315)76:4<639::AID-JCB12>3.0.CO;2-I |
0.452 |
|
| 1998 |
Patton AJ, Genever PG, Birch MA, Suva LJ, Skerry TM. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone Bone. 22: 645-649. PMID 9626403 DOI: 10.1016/S8756-3282(98)00061-1 |
0.388 |
|
| 1998 |
Noel LS, Champion BR, Holley CL, Simmons CJ, Morris DC, Payne JA, Lean JM, Chambers TJ, Zaman G, Lanyon LE, Suva LJ, Miller LR. RoBo-1, a novel member of the urokinase plasminogen activator receptor/CD59/Ly-6/snake toxin family selectively expressed in rat bone and growth plate cartilage. The Journal of Biological Chemistry. 273: 3878-83. PMID 9461570 DOI: 10.1074/Jbc.273.7.3878 |
0.387 |
|
| 1997 |
Mason DJ, Suva LJ, Genever PG, Patton AJ, Steuckle S, Hillam RA, Skerry TM. Mechanically regulated expression of a neural glutamate transporter in bone: A role for excitatory amino acids as osteotropic agents? Bone. 20: 199-205. PMID 9071469 DOI: 10.1016/S8756-3282(96)00386-9 |
0.461 |
|
| 1994 |
Rodan G, Harada S, Suva L, Tanaka H, Rodan S. 8. Gene expression in osteoblast cells Bone. 15: 226-227. DOI: 10.1016/8756-3282(94)90719-6 |
0.364 |
|
| 1993 |
Suva LJ, Seedor JG, Endo N, Quartuccio HA, Thompson DD, Bab I, Rodan GA. Pattern of gene expression following rat tibial marrow ablation Journal of Bone and Mineral Research. 8: 379-388. PMID 8456591 |
0.332 |
|
| 1989 |
Martin TJ, Suva LJ. Parathyroid hormone-related protein in hypercalcaemia of malignancy Clinical Endocrinology. 31: 631-647. PMID 2697477 DOI: 10.1111/j.1365-2265.1989.tb01288.x |
0.321 |
|
| 1987 |
Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, Hudson PJ, Martin TJ, Wood WI. A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression Science. 237: 893-896. PMID 3616618 DOI: 10.1126/Science.3616618 |
0.392 |
|
| 1986 |
Eisman JA, Suva LJ, Martin TJ. Significance of 1, 25-Dihydroxyvitamin D 3 Receptor in Primary Breast Cancers Cancer Research. 46: 5406-5408. PMID 3019526 |
0.34 |
|
| 1984 |
Eisman JA, Suva LJ, Frampton RJ. 1,25-Dihydroxyvitamin D3 and breast cancer Australian and New Zealand Journal of Surgery. 54: 17-20. PMID 6326729 |
0.31 |
|
| 1982 |
Frampton RJ, Suva LJ, Eisman JA, Findlay DM, Moseley JM, Martin TJ, Moore GE. Presence of 1,25-Dihydroxyvitamin D3 Receptors in Established Human Cancer Cell Lines in Culture Cancer Research. 42: 1116-1119. PMID 6277475 |
0.308 |
|
| 1981 |
Eisman JA, Pearce PJ, Suva LJ, Funder JW, Sher E, Martin TJ. Frequency of 1,25-Dihydroxyvitamin D3 Receptor in Human Breast Cancer Cancer Research. 41: 5121-5124. PMID 6272989 |
0.338 |
|
| Show low-probability matches. |